Cargando…

Ursodeoxycholic acid enriches intestinal bile salt hydrolase-expressing Bacteroidetes in cholestatic pregnancy

Ursodeoxycholic acid (UDCA) treatment can reduce itch and lower endogenous serum bile acids in intrahepatic cholestasis of pregnancy (ICP). We sought to determine how it could influence the gut environment in ICP to alter enterohepatic signalling. The gut microbiota and bile acid content were determ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ovadia, Caroline, Perdones-Montero, Alvaro, Fan, Hei Man, Mullish, Benjamin H., McDonald, Julie A. K., Papacleovoulou, Georgia, Wahlström, Annika, Ståhlman, Marcus, Tsakmaki, Anastasia, Clarke, Louise C. D., Sklavounos, Alexandros, Dixon, Peter H., Bewick, Gavin A., Walters, Julian R. F., Marschall, Hanns-Ulrich, Marchesi, Julian R., Williamson, Catherine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054423/ https://www.ncbi.nlm.nih.gov/pubmed/32127609 http://dx.doi.org/10.1038/s41598-020-60821-w

Ejemplares similares

Obeticholic acid improves fetal bile acid profile in a mouse model of gestational hypercholanemia
por: Pataia, Vanessa, et al.
Publicado: (2020)

Pilot study with IBAT inhibitor A4250 for the treatment of cholestatic pruritus in primary biliary cholangitis
por: Al-Dury, Samer, et al.
Publicado: (2018)

Enhanced Microbial Bile Acid Deconjugation and Impaired Ileal Uptake in Pregnancy Repress Intestinal Regulation of Bile Acid Synthesis
por: Ovadia, Caroline, et al.
Publicado: (2019)

Ursodeoxycholic acid improves feto-placental and offspring metabolic outcomes in hypercholanemic pregnancy
por: Borges Manna, Luiza, et al.
Publicado: (2020)

Tetrahydroxylated bile acids improve cholestatic liver and bile duct injury in the Mdr2(−/−) mouse model of sclerosing cholangitis via immunomodulatory effects
por: Fuchs, Claudia D., et al.
Publicado: (2022)

Colesevelam attenuates cholestatic liver and bile duct injury in Mdr2(−/−) mice by modulating composition, signalling and excretion of faecal bile acids
por: Fuchs, Claudia Daniela, et al.
Publicado: (2018)

Ileal Bile Acid Transporter Inhibition for the Treatment of Chronic Constipation, Cholestatic Pruritus, and NASH
por: Al-Dury, Samer, et al.
Publicado: (2018)

Ursodeoxycholic Acid in Treatment of Non-cholestatic Liver Diseases: A Systematic Review
por: Reardon, Jillian, et al.
Publicado: (2016)

Cyp3a11 is not essential for the formation of murine bile acids
por: Wahlström, Annika, et al.
Publicado: (2017)

Intrahepatic Cholestasis of Pregnancy Levels of Sulfated Progesterone Metabolites Inhibit Farnesoid X Receptor Resulting in a Cholestatic Phenotype
por: Abu-Hayyeh, Shadi, et al.
Publicado: (2013)

Commensal Bacteroidetes protect against Klebsiella pneumoniae colonization and transmission through IL-36 signalling
por: Sequeira, Richard P., et al.
Publicado: (2020)

The Reversed Feto-Maternal Bile Acid Gradient in Intrahepatic Cholestasis of Pregnancy Is Corrected by Ursodeoxycholic Acid
por: Geenes, Victoria, et al.
Publicado: (2014)

A multi-centered trial investigating gestational treatment with ursodeoxycholic acid compared to metformin to reduce effects of diabetes mellitus (GUARD): a randomized controlled trial protocol
por: Lovell, Holly, et al.
Publicado: (2022)

Variant adiponutrin confers genetic protection against cholestatic itch
por: Krawczyk, Marcin, et al.
Publicado: (2014)

Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity
por: Mueller, Michaela, et al.
Publicado: (2015)

Enzymatic quantification of total serum bile acids as a monitoring strategy for women with intrahepatic cholestasis of pregnancy receiving ursodeoxycholic acid treatment: a cohort study
por: Manna, LB, et al.
Publicado: (2019)

Microbiome and metabolic disease: revisiting the bacterial phylum Bacteroidetes
por: Johnson, Elizabeth L., et al.
Publicado: (2016)

Ursodeoxycholic acid: Effects on hepatic unfolded protein response, apoptosis and oxidative stress in morbidly obese patients
por: Mueller, Michaela, et al.
Publicado: (2017)

Paternal cholestasis exacerbates obesity-associated hypertension in male offspring but is prevented by paternal ursodeoxycholic acid treatment
por: Pataia, Vanessa, et al.
Publicado: (2018)

Colitis ameliorates cholestatic liver disease via suppression of bile acid synthesis
por: Gui, Wenfang, et al.
Publicado: (2023)

SAT-086 A Rare Case of Cholestatic Liver Disease Causing Markedly Elevated LDL Successfully Managed with Plasmapheresis and Ursodeoxycholic Acid
por: Lee, Yee Liong, et al.
Publicado: (2019)

Epidermal growth factor signaling protects from cholestatic liver injury and fibrosis
por: Svinka, Jasmin, et al.
Publicado: (2016)

The Importance of Gestation-Adjusted Birthweight Centile in Assessment of Fetal Growth in Metabolic Conditions
por: Ovadia, Caroline, et al.
Publicado: (2018)

Dihydroartemisinin-Ursodeoxycholic Bile Acid Hybrids in the Fight against SARS-CoV-2
por: Marchesi, Elena, et al.
Publicado: (2023)

Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection
por: Mullish, Benjamin H, et al.
Publicado: (2019)

Obeticholic acid ameliorates dyslipidemia but not glucose tolerance in mouse model of gestational diabetes
por: McIlvride, Saraid, et al.
Publicado: (2019)

Diabetes through a 3D lens: organoid models
por: Tsakmaki, Anastasia, et al.
Publicado: (2020)

Environmental and Gut Bacteroidetes: The Food Connection
por: Thomas, François, et al.
Publicado: (2011)

Genome-Based Taxonomic Classification of Bacteroidetes
por: Hahnke, Richard L., et al.
Publicado: (2016)

Fat Malabsorption and Ursodeoxycholic Acid Treatment in Children With Reduced Organic Solute Transporter-α (SLC51A) Expression
por: Tronstad, Rune Rose, et al.
Publicado: (2022)

Hepatocyte specific expression of an oncogenic variant of β-catenin results in cholestatic liver disease
por: Lemberger, Ursula J., et al.
Publicado: (2016)

Evaluation of the Anticancer Activity of a Bile Acid-Dihydroartemisinin Hybrid Ursodeoxycholic-Dihydroartemisinin in Hepatocellular Carcinoma Cells
por: Huang, Tzu-En, et al.
Publicado: (2020)

Corrigendum: Genome-Based Taxonomic Classification of Bacteroidetes
por: Hahnke, Richard L., et al.
Publicado: (2018)

A novel class of polymorphic toxins in Bacteroidetes
por: Jana, Biswanath, et al.
Publicado: (2020)

Degradation of complex arabinoxylans by human colonic Bacteroidetes
por: Pereira, Gabriel V., et al.
Publicado: (2021)

The role of bile acids in cholestatic liver injury
por: Cai, Shi-Ying, et al.
Publicado: (2021)

Severe cholestatic jaundice after a single administration of ajmaline; a case report and review of the literature
por: Mullish, Benjamin H, et al.
Publicado: (2014)

The implementation of omics technologies in cancer microbiome research
por: Mullish, Benjamin H, et al.
Publicado: (2018)

Bacterial and metabolic phenotypes associated with inadequate response to ursodeoxycholic acid treatment in primary biliary cholangitis
por: Martinez-Gili, Laura, et al.
Publicado: (2023)

Biological synthesis of ursodeoxycholic acid
por: Song, Peng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v93at87242hlaenek174srbvqq